The information obtained from crystallized complexes of the Na + ,K + -ATPase with cardiotonic steroids (CTS) is not sufficient to explain differences in the inhibitory properties of CTS such as stereoselectivity of CTS binding or effect of glycosylation on the preference to enzyme isoforms. The uncertainty is related to the spatial organization of the hydrophilic cavity at the entrance of the CTS-binding site. Therefore, there is a need to supplement the crystallographic description with data obtained in aqueous solution, where molecules have significant degree of flexibility. This work addresses the applicability of the electron paramagnetic resonance (EPR) method for the purpose. We have designed and synthesized spin-labeled compounds based on the cinobufagin steroid core. The length of the spacer arms between the steroid core and the nitroxide group determines the position of the reporting group (N-O) confined to the binding site. High affinity to Na + ,K + -ATPase is inferred from their ability to inhibit enzymatic activity. The differences between the EPR spectra in the absence and presence of high ouabain concentrations identify the signature peaks originating from the fraction of the spin labels bound within the ouabain site. The degree of perturbations of the EPR spectra depends on the length of the spacer arm. Docking of the compounds into the CTS site suggests which elements of the protein structure might be responsible for interference with the spin label (e.g., steric clashes or immobilization). Thus, the method is suitable for gathering information on the cavity leading to the CTS-binding site in Na 
The information obtained from crystallized complexes of the Na + ,K + -ATPase with cardiotonic steroids (CTS) is not sufficient to explain differences in the inhibitory properties of CTS such as stereoselectivity of CTS binding or effect of glycosylation on the preference to enzyme isoforms. The uncertainty is related to the spatial organization of the hydrophilic cavity at the entrance of the CTS-binding site. Therefore, there is a need to supplement the crystallographic description with data obtained in aqueous solution, where molecules have significant degree of flexibility. This work addresses the applicability of the electron paramagnetic resonance (EPR) method for the purpose. We have designed and synthesized spin-labeled compounds based on the cinobufagin steroid core. The length of the spacer arms between the steroid core and the nitroxide group determines the position of the reporting group (N-O) confined to the binding site. High affinity to Na + ,K + -ATPase is inferred from their ability to inhibit enzymatic activity. The differences between the EPR spectra in the absence and presence of high ouabain concentrations identify the signature peaks originating from the fraction of the spin labels bound within the ouabain site. The degree of perturbations of the EPR spectra depends on the length of the spacer arm. Docking of the compounds into the CTS site suggests which elements of the protein structure might be responsible for interference with the spin label (e.g., steric clashes or immobilization). Thus, the method is suitable for gathering information on the cavity leading to the CTS-binding site in Na Introduction Na + ,K + -ATPase is an enzyme critical for the survival of animal cells. Its activity maintains an uneven distribution of Na + and K + ions over the membrane, the basis for the resting membrane potential and excitability, as well as the driving force for transport of nutrients and other ions [1] . The central role of the Na + , K + -ATPase in metabolism is reflected in the evolutionary development of poisons and venoms targeting this enzyme. Most of them belong to a large family of cardiotonic steroids (CTS or cardiac glycosides), and the sensitivity toward these compounds is considered as a hallmark of Na with three different CTS: bufalin (nonglycosylated with six-membered lactone ring), ouabain (one sugar unit, five-membered lactone ring), and digoxin (heavily glycosylated, five-membered ring) [2, 3] . As expected, the ligands plug the entrance to the ion-binding sites from the extracellular side. The transmembrane helices forming the binding pocket are highly superimposable (with the exception of the loop of aM1-2), consequently, the binding modes of the ligands also revealed similar tracks.
The available structural information, however, is not sufficient to explain certain kinetic observations. Thus, comparison of inhibitory properties of different stereoisomers of bufadienolides showed that all b-stereoisomers are more potent compared to astereoisomers [4] . Even for the bufalin molecule, the anomerization of the OH-group shifted the inhibition curve and decreased affinity of binding to the a1b1 Na + ,K + -ATPase from nM (b-form) to tenth lM (aform). It should be stressed that, according to the crystal structure, b-bufalin is placed almost perpendicular to the membrane surface, with the lactone located in a hydrophobic funnel, leading to the cation-binding sites. There are no anticipations of interactions around the OH-group or clashes with the side chains in the vicinity of the entrance to the binding site.
A positive effect of glycosylation on CTS affinity toward the Na + ,K + -ATPase and its contribution to Na + ,K + -ATPase isoform selectivity (at least in the case of digoxin and digitoxin) [5] represents another riddle, since in the crystal structure the sugar moiety is found near extracellular loops, with no indications of firm interactions with the side chains. Thus, there is a need to supplement the crystallographic description of the Na + ,K + -ATPase-CTS complexes with the data obtained in aqueous solution, where the molecules have a certain degree of flexibility. This paper addresses the applicability of the electron paramagnetic resonance (EPR) method for this purpose.
We have designed and synthesized spin-labeled cinobufagins where different spacer arms allow variation in the distance between the steroid core and the nitroxide group. Thus, the reporting group (N-O) is placed in different depths within the binding site. In an earlier study, spin-labeled ouabain was used to characterize the motion of the whole oligomeric complex [6, 7] . In the present paper, the degree of perturbation of EPR spectra, possibly due to increased motional restriction, characterizes the binding cavity at the chosen distance from the steroid core and correlates with the length of the spacer arm. This information together with results of the docking studies affords a description of the cavity leading to the CTS-binding site in a1b1 Na 
Results and Discussion
Many CTS have one to four carbohydrate residues attached at 3b-OH of the steroid core, for example, ouabain has one and digoxin three sugar moieties, and all of these are found in the wide cavity on the extracellular side of the Na + ,K + -ATPase. Therefore, the 3b-OH site is an obvious choice for derivatization and attachment of a nitroxide group. Cinobufagin is used as a CTS core for the design of EPR probes. This ensures binding within the specific site, while spacer arms varying in length and structure place the spin label at different depths in the cavity. The structures of seven synthesized EPR probes (C-1 to C-7) are presented in Fig. 1 (see Materials and methods for details of chemical synthesis and characterization of the EPR probes).
Inhibitory activities of cinobufagin spin labels on Na + ,K + -ATPase
The performed derivatization should not prevent specific binding of the compound in the CTS-binding site, that is, the ability to inhibit enzyme with high affinity. Inhibitory potencies were determined from the residual Na + ,K + -ATPase hydrolytic activities after incubation with varying concentrations of the derivatives using our reported method [4] (Fig. 2) . The results were fitted with hyperbolic functions corresponding to a dominant high-affinity component and a second smaller low-affinity component. The resulting kinetic parameters are summarized in Table 1 . C-1 revealed a high inhibitory potency with a K Diss value of 0.15 AE 0.004 lM for the high-affinity component. The labels C-4 to C-7 all had K Diss values between 0.24 and 0.84 lM, whereas labels C-2 and C-3 had lower inhibitory activity. The inhibitory potency of all labels was large enough to allow for a high degree of spin-labeling of the enzyme at the specific site. The conformational equilibrium constant K C derived from the inactivation patterns varies between about 2 and 6.7 ( Table 1 ), suggesting that between 67% and 87% of the enzyme molecules cannot release inhibitor directly (see Materials and methods and references therein for details of the kinetic analysis). The kinetic parameters are discussed below in relation to heterogeneity of the EPR signals from bound inhibitor.
EPR spectroscopy results

Verification of the method
Theoretically, the spin-labeled compound added to the native membrane preparation of the Na + ,K + -ATPase may be localized in four different environments. Fig. 3 depicts Na + ,K + -ATPase (PDB ID 4HYT) embedded in the membrane and cinobufagin spin labels are shown as orange rectangles.
There are four possible loci, where binding to sites A, B, and C might diminish the mobility of the spin label, and locus D refers to solvent phase, where the spin label moves freely. Only locus A represents the CTS-binding site of the Na + ,K + -ATPase and is, therefore, saturable. Loci B, C, and D are nonspecific and for all practical purposes nonsaturable. Fractions of the spin label located in each locus will be characterized by signature peaks in the EPR spectrum, dependent on their mobility. Ouabain at a high concentration will prevent binding of the cinobufagin spin label to the specific binding site (A), that is, the signal from the spin label in the CTS site will disappear from the EPR spectrum, but will not affect interactions with other sites.
The above theoretical considerations were fully confirmed by the EPR spectra. Fig. 4 represents data for C-1 -C-3 added to the membranes containing Na Fig. 4 is chosen to give an EPR signal with contributions primarily from the specifically bound label (Locus A). From the inhibitory potencies (Table 1) it can be calculated that between 85% and 98% of the labels C-1 to C-3 are bound to the specific binding sites. In the absence of ouabain, spectra of all three spin labels have broad peaks in the low-field region and these peaks are very much reduced by the addition of ouabain (red lines in Fig. 4) .
The EPR spectra on Fig. 4 have been normalized (to 100%) to allow for a quantitative comparison of the line shapes with and without ouabain present. For C-1 we find a K Diss = 0.15 lM (Table 1) , and with the used concentrations of spin label (4 lM) and enzyme (12 lM) the amount of specifically bound spin label reaches 98.2%. The residual 1.8% of the spin label is found in the nonspecific sites. The cyan line in Fig. 4A illustrates the negligible contribution from the spin label bound to the nonspecific sites to the total spectrum (black line) under these conditions.
With the overwhelming majority of the spin label bound to the CTS site, the shapes of spectra in the low-field region points to a heterogeneous environment of the spin label. For C-1 there is a marked sharp peak in addition to a broader low-field line, while for C-2 and C-3 the peaks show significant overlap. Ouabain induces changes in the low-field region confirming that the heterogeneity originates from the binding modes in the CTS site. It is, therefore, possible that this heterogeneity in the EPR spectrum is related to the equilibrium between the two complexes of the enzyme with spin label bound: E•I ↔ E•I* (see Materials and methods for details). Fig . 5 demonstrates the changes in the normalized spectra in response to increasing probe (C-1) concentrations. In the presence of ouabain (Fig. 5A ), the spectra have the same shape independently on concentration used (from 12 to 72 lM in the presence of 36 lM enzyme). This implies that the probe is to be found only in the nonsaturable nonspecific sites (B, C, D) (while the CTS-binding site is occupied by ouabain) and that the relative proportions of B, C, and D are independent of the total concentration of spin label (up to 72 lM).
In the absence of ouabain (Fig. 5B ), the low-field peak changes height. The saturation of the specific site changes between relatively low, intermediate, and full saturation as the spin label concentration is increased. It is also evident that the proportion between nonspecifically vs. specifically bound probes increases.
The outer hyperfine splitting 2A max for C-1 of about 67.9 G is the same as we earlier found for the maleimide spin labels (6-MSL in Table 1 The normalized spectra for a sample with enzyme (12 lM) in buffer and 4 lM C-1 in the absence (black line) and in the presence of 0.5 mM ouabain (redline). In addition, the spectrum with ouabain is also shown scaled to 1.8% (cyan line). (B) The normalized spectra for a sample with enzyme (12 lM) in buffer and 4 lM C-2 in the absence (black line) and in the presence of 0.5 mM ouabain (red line). In addition, the spectrum with ouabain is also shown scaled to 12.8% (cyan line). (C) The normalized spectra for a sample with enzyme (12 lM) in buffer and labeled with 4 lM C-3 in the absence (black line) and in the presence of 0.5 mM ouabain (red line). In addition, the spectrum with ouabain is also shown scaled to 15.3% (cyan line). Samples were centrifuged before EPR. Temperature 26°C. Total scan width 100 G. 67.7 G. The linewidth (here measured as width at half height) of the low-field peak is about 2.5 G compared to 3.7 G for 6-MSL [8] and the corresponding value is about 2.9 G for the high-field line, compared to about 4.9 G for 6-MSL [8] . The lower values for C-1 indicate a more immobilized type of spectrum for C-1 than for the maleimide spin label bound to Class II groups of the Na
. Based on the above results and considerations, the EPR signals observed from the probes bound to the membranous preparation of the Na + ,K + -ATPase were assigned to loci A, B, and C, Fig. 5 . Binding in site (A) results in intensity in the low-field region of the spectrum in the absence of ouabain, and it appears that specific binding of C-1 leads to two distinct types of signal (marked with arrows in Fig. 5B ). The fraction of the spin label dissolved in the bilayer is heterogeneous since they occupy locus C, with rapid rotational motion reflected by the sharpness of the line, and locus B, where the spin label interacts with the protein boundary which restricts the motion (Fig. 5A ). There is virtually no signal from the spin labels in the aqueous phase (D) for this label. In Correlation between the length of the spacer arm and perturbation of the spin label bound within the CTSbinding site
The spin-labeled derivatives C-4 to C-7 comprise a family of homologous structures, differing only in length of the spacer arms. The comparison is straightforward, since the distance between the steroid core and the nitroxide spin label increases gradually due to the addition of CH 2 groups. Spectra in Fig. 6 are normalized for convenience and stacked according to the length of the spin label.
In the presence of ouabain (Fig. 6A ), the spectra are roughly similar, and the positions of signature peaks for labels in loci B and C are similar to those in Fig. 5 , while the very sharp peaks in C-4 and C-5 spectra are presumably due to spin labels in the aqueous phase (locus D).
In an attempt to quantitate this similarity, the lineheights at about 3299 Gauss (corresponding to locus Cinobufagin spin-label Fig. 6 . EPR spectra of spin-labeled pig kidney Na + ,K + -ATPase. (A) Spectra are for samples with enzyme (12 lM) in buffer and 0.5 mM ouabain, labeled with 4 lM C-4 (black), C-5 (red), C-6 (cyan), and C-7 (blue), respectively (top to bottom). The peaks marked "B," "C," and "D" in the C-4 spectrum are related to nonspecifically bound spin label at loci B or C or label in aqueous solution (locus D, Fig. 3 ). (B) Spectra are for samples with enzyme (12 lM) in buffer labeled with 4 lM C-4 (black), C-5 (red), C-6 (cyan), and C-7 (blue), respectively (top to bottom), in the absence of ouabain. In addition, calculated spectra from nonspecifically bound labels are shown as dotted lines. The approximate positions of the peaks originated from locus A are indicated. Samples were centrifuged before EPR. Temperature 26°C. Total scan width 100 G. (C) The ratio of the lineheights at about 3299 Gauss and at 3290.5 Gauss (read from spectra shown in Figs. 4 and 6) are shown for the seven spin labels C-1 to C-7 in the presence of 0.5 mM ouabain (open black squares) as well as in the absence of ouabain (for C-5 to C-7, filled black squares). In addition the linewidth of the sharp line at about 3299 G is given for spin label in the presence of 0.5 mM ouabain (open red circles) as well as in the absence of ouabain (for C-5 to C-7, filled red circles). C) and that at 3290.5 Gauss (corresponding to locus B) were read from the ouabain spectra of Figs. 4 and 6, and the signal ratio "3299 G"/"3290.5 G" was calculated and shown in Fig. 6C with an average of 8.8 AE 0.9. The linewidth of the sharp low-field line (at locus B, here measured as the peak-to-trough distance) is also similar for the seven labels (average about 2.9 G AE 0.3 G). The peak-to-peak distance of the sharp lines in the outer wings of the spectra for the "type C" labels is also similar (average about 36.6 AE 0.7 G, data not shown). Thus, the overall spectral characteristics of nonspecifically bound spin labels appear to be independent of the length of the spacer arm.
In the absence of ouabain, spectra vary significantly from analog to analog (Fig. 6B) . In these cases, the contributions from the nonspecifically bound spin labels can be estimated using the spectra in Fig. 6A and the K Diss values from Table 1 , as described in Section Details of the kinetic analysis of inhibition. These responses are shown as dotted lines in Fig. 6B to illustrate a very small contribution from the spin labels in loci B, C, and D to the overall EPR spectra obtained in the absence of ouabain.
Comparison of the responses in the presence or absence of ouabain allows assignment of the broad component in the low-field part of the C-4 spectrum to the signal from the probe bound within the CTS site (locus A). The size and the shape of the low-field component show a correlation with the length of the spacer arm. C-4 appears more affected (possibly motion restricted) in the EPR spectrum compared to the longer labels C-5 to C-7.
For the labels C-5, C-6, and C-7, the linewidth of the sharp low-field line (here measured as the peak-totrough distance) shows a clear decrease from about 5 G for C-5 to about 3 G for C-7, Fig. 6C , possibly indicating an increase in motional freedom at the longer spacer arms. The peak-to-peak distance for the major peaks in the outer wings of the spectrum also show a decrease (from about 44 G to about 39 G), also indicating gradually increased motional freedom. The gradual increase in intensity ratio "3299 G"/ "3290.5 G" in the row C-5, C-6, and C-7 in the absence of ouabain suggests that there is very little low-field absorption as the distance between the steroid nucleus and the spin label moiety increases. A very small fraction of the spin label C-7 bound at the Alocus absorbs at low fields compared to the conditions when C-7 is found only in loci B and C in the presence of ouabain (Fig. 6 and 3) .
It is possible that the broad peak for C-4 is the sum of two close peaks. It is tempting to interpret the results of the inactivation kinetics as follows: the bound spin label is distributed between two protein conformations E•I ↔ E•I* which are present at a 1 : 3 ratio (K c = 3, Table 1 ). These two will have absorption maxima in the low-field part of the EPR spectrum in the 3290-3296 G range (cf. Fig. 6B ). We are currently undertaking a lineshape analysis of this broad peak to interpret the results of the inactivation kinetics with the aim of describing the difference between the structure of the initial binding state E•I and the fully bound form E•I*.
In summary, the consistent changes in the spectral characteristics of the spin-labeled derivatives C-4 to C-7 possibly indicate an increase in mobility as the length of the spacer arm in increased. The shortest spacer arm (in C-4) correlates with the most motionalrestricted (broad) peak in the low-field part of the spectrum.
Docking of cinobufagin derivatives into the CTSbinding site of Na + ,K + -ATPase
The crystal structure of pig kidney Na, K-ATPase in complex with bufalin (PDB ID 4RES) was used for the docking of spin-labeled derivatives. Fig. 7 shows that cinobufagins have a binding mode similar to that of bufalin in the crystal complex. It seems, however, that orientation of the steroid core of cinobufagin in the binding cavity might vary slightly and that the substituent (linker and spin label) has a tendency to pull the molecule upward in the cavity compared to bufalin.
Variations in the position of the spin label in the upper part of the cavity were more significant for C-7 (Fig. 7B ) compared to C-4 (Fig. 7A) . Potential ligand poses generated by the docking program placed the spin label group in C-4 in the proximity to the extracellular loop M1-M2. The question, whether a spatial restriction or a specific interaction with the protein is responsible for this relatively rigid binding mode, remains unresolved.
For the C-7 derivative, the long linker either brings the spin label well out into the extracellular matrix or bends and directs it toward the protein cavity. The former orientation yields probably the very sharp EPR peak at 3299 G. The spin labels interacting within the protein cavity could give rise to low-field intensity in the EPR spectra suggesting lower mobility. The very high ratio "3299 G"/"3290.5 G" for C-7 (cf. Fig. 6C ), however, suggests that only a small fraction of these spin labels are actually located within the cavity. We have attempted to illustrate this in Fig. 7C , where a set of C-7 spin labels illustrate the more extended forms of the C-7 spin labels. Here, the steroid moiety is docked as in panels A and B, but the spin label group is allowed to stretch into the aqueous phase. It is conceivable that these spin labels will experience a much larger degree of motional freedom than, for example, C-4 (cf. Fig. 7A ), giving rise to the dominant sharp lines shown for C-7 in Fig. 6B .
In conclusion, the results illustrate that the EPR approach is suitable for detailed characterization of the extracellular cavity of the Na + ,K + -ATPase-CTSbinding site. It supplements and verifies the existing description of crystallized enzyme-CTS complexes since it is able to provide information valid under physiological conditions in aqueous solutions. The degree of perturbation of the spin label reflects the interactions within the cavity at the chosen distance from the steroid core, that could, for example, limit its mobility. This interaction, in turn, may be identified by docking studies. Compilation of the data will allow mapping of the surface of the CTS-binding site. Since both the chemical structure and the length of the spacer affect the spectral characteristics of the nitroxide label we expect to identify the specific amino acid residues as points of contact.
Materials and methods
General synthetic procedures
We used the nitroxyl-free radical as the reporting group, and attached it to the steroid core of cinobufagin through different linkers. Cinobufagin was purchased from Shanxi Chenguang Biological Technology Co. Ltd with purity ≥ 98%. 4-hydroxy-2,2,6,6-tetramethylpiperidine (4-OH-TEMPO) was purchased from Aladdin (Shanghai, China) and used without further purification. All other commercially available reagents were used as received unless stated otherwise. NMR data were collected on a Bruker Ò 300 MHz spectrometer at ambient temperature with the residual solvent peaks as internal standards. Chemical shifts were given in ppm with respect to the TMS signal and coupling constants (J) were given in Hz. ESI-HR-MS were obtained using Agilent 6210 LC/MSD TOF mass spectrometer (Palo Alto, USA). EPR spectra were obtained with JES-FA200 X-band EPR spectrometer at ambient temperature. Optical rotations were measured using a JASCO P-2000 polarimeter (Tokyo, Japan) at 22-24°C in CH 3 OH. IR spectra were obtained using a JASCO FT/IR-4600 Fourier Transform Infrared spectrometer. The 200-300 and 300-400 mesh silica gel (Qingdao Ocean Chemical Factory, P. R. China) was used for TLC and column chromatography, respectively. All air-or moisture-sensitive reactions were operated using dry solvents under argon atmosphere.
Synthesis of nitroxides with different linkers 3, 4, and 6a-d
The synthesis routes are outlined in Fig. 8 . ESI-HR-MS analyses of the compounds are given in Figs S1-S6.
Synthesis of compounds 2a-d
A suspension of compound 1a-d (1 g) in methanol (20 mL) was added thionyl chloride at 0°C under argon atmosphere. Then, the mixture was allowed to reach room temperature and stirred for 16 h. After the reactant was consumed completely, the solution was evaporated to dryness under reduced pressure, and the residue was redissolved in 10 mL methanol and then concentrated. The above procedure was repeated twice to remove thionyl chloride in excess. At last, the crude material was recrystallized from ethyl acetate to give the white solid compound 2a-d.
Synthesis of compound 3
To a solution of 4-OH-TEMPO (100 mg, 0.58 mmol, 1.0 equiv.), Bromoacetic acid (121 mg, 0.87 mmol, 1.5 equiv.) and DMAP (14 mg, 0.12 mmol, 0.2 equiv.) in 5 mL anhydrous dichloromethane was added EDCI (222 mg, 1.2 mmol, 2.0 equiv.), then the solution was stirred at room temperature under atmosphere overnight. The reaction mixture was diluted with 30 mL dichloromethane and extracted with water (50 mL). The aqueous layer was extracted with dichloromethane (20 mL) twice. The combined organic layer was washed with saturated NaHCO 3 solution (3 9 10 mL) and saturated NaCl solution (3 9 10 mL), then dried over anhydrous sodium sulfate and filtered. The resulting solution was concentrated in vacuum to give the red liquid, which was purified by column chromatography on silica gel (petroleum ether/ethyl acetate = 20 : 1) to afford compound 3 (158 mg, 0.54 mmol, 93%) as red solid powder.
Synthesis of compound 4
4-OH-TEMPO (1 g, 5.8 mmol, 1.0 equiv.) was added slowly to the suspension of NaH (697 mg, 60% in mineral oil, 11.6 mmol, 3.0 equiv.) in anhydrous THF (200 mL) at 0°C. Subsequently, bromoacetic acid was added, then the solution was heated under gentle reflux under argon for 18 h. After the reaction mixture was cooled to room temperature, water (20 mL) was added carefully, the resultant dark orange solution was concentrated to 50 mL and transferred to a separation funnel. The aqueous layer was washed with diethyl ether (3 9 20 mL) and dichloromethane (3 9 20 mL) in sequence and then acidified with 10% acetic acid to pH 6-7. The acidified aqueous layer was extracted with dichloromethane (3 9 30 mL). The combined organic layer was dried with anhydrous sodium sulfate, filtered, and concentrated under reduce pressure. The residue was purified by flash silica gel column chromatography (chloroform/methanol = 15 : 1) to achieve compound 4 (978 mg, 4.3 mmol, 73%) as red oil.
Synthesis of compounds 5a-d
Compound 1 (200 mg, 0.9 mmol, 1.0 equiv.) and the corresponding compound 2a-d (1.2 equiv.) were dissolved in a solution consisting of 3 mL anhydrous DMF and 1 mL anhydrous dichloromethane, then 0.2 mL 4-methylmorpholine (NMM, 176 mg, 1.7 mmol, 2.0 equiv.) was added. After the mixture was cooled to 0°C using ice bath, 0.15 mL isobutyl chloroformate (IBCF, 1.1 mmol, 1.3 equiv.) was added dropwise. The above solution was stirred overnight under argon after warming to room temperature. The reaction mixture was extracted with dichloromethane (25 mL) twice, and then the combined organic layer was washed with water (3 9 10 mL), saturated NaHCO 3 solution (3 9 10 mL) and saturated NaCl solution (3 9 10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography (cyclohexane/ethyl acetate = 3 : 1) to afford compound 5a-d as red oil.
Synthesis of compounds 6a-d
This synthesis was done using the reported method [9] . To a solution of compound 5a-d (100 mg) in 2 mL methanol, 60 mg LiOH in 1 mL water was added, then the reaction mixture was stirred at room temperature for 3-4 h. After the reaction was completed as monitored by TLC, the resultant solution was concentrated to remove the methanol. The residue was dissolved in dichloromethane and then extracted. The aqueous layer was carefully acidified with 1N hydrochloric acid to pH 2-3 then extracted with dichloromethane (20 mL) twice. The combined organic layer was washed with water (3 9 10 mL) and saturated NaCl solution (3 9 10 mL), dried with anhydrous sodium sulfate, filtered, and concentrated in vacuum to obtain the compound 6a-d as red powder. The physical and spectroscopy characters of compounds 3, 4, and 6a-d were listed in Table S1 .
Synthesis of spin-labeled cinobufagins C-1 to C-7
The synthesis routes are outlined in Fig. 9 .
Synthesis of compound 7
Succinic anhydride (23 mg, 0.23 mmol, 2.0 equiv.) was added to a solution of cinobufagin (50 mg, 0.13 mmol, 1.0 equiv.) and DMAP (28 mg, 0.23 mmol, 2.0 equiv.) in 5 mL anhydrous dichloromethane, the solution was refluxed gently under argon for 8 h. After the reactant was consumed completely, the solution was diluted with 20 mL dichloromethane and extracted with water. The organic layer was washed with water (3 9 10 mL) and saturated NaCl solution (3 9 10 mL), dried with anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to give compound 7 as white solid (52 mg, 95 lmol, 85%). The NMR data of 7 (Fig. S7) were similar to the parent compound cinobufagin [10] (Fig. S8) .
Synthesis of compound C-1
To a solution of cinobufagin (30 mg, 68 lmol, 1.0 equiv.) and DMAP (2 mg, 14 lmol, 0.2 equiv.) in 3 mL anhydrous dichloromethane was added compound 4 (19 mg, 81 lmol, 1.2 equiv.), the solution was cooled to 0°C using ice bath and then 20 lL DIC (17 mg, 136 lmol, 2.0 equiv.) was added dropwise. After the addition was completed, the reaction mixture was allowed to reach room temperature and stirred under argon for 24 h. Then, the solution was diluted with 15 mL dichloromethane and extracted with water. The organic layer was washed with saturated NaHCO 3 solution and saturated NaCl solution in sequence, dried with anhydrous sodium sulfate, filtered, and evaporated to dryness. The resulting residue was subjected to flash silica gel column chromatography (petroleum/ethyl acetate = 5 : 1) give the compound C-1 (33 mg, 50 lmol, 74%) as red powder. Analytical results are shown in Figs S9 (ESI-HR-MS) and S10 (IR spectral analysis).
Synthesis of compound C-2
Compound 7 (20 mg, 37 lmol, 1.0 equiv.), 4-OH-TEMPO (7 mg, 40 lmol, 1.1 equiv.) and DMAP (2 mg, 18 lmol 0.5 equiv.) were dissolved in 3 mL anhydrous dichloromethane, then EDCI (15 mg, 74 lmol, 2.0 equiv.) was added. The above solution was stirred under argon at room temperature overnight. Then, the reaction mixture was diluted with 15 mL dichloromethane and extracted with water. The organic layer was washed with saturated NaHCO 3 solution and saturated NaCl solution, dried with anhydrous sodium sulfate, filtered, and concentrated in vacuum. The residue was purified by silica gel column chromatography (petroleum/ethyl acetate = 3 : 1) to afford compound C-2 (22 mg, 32 lmol, 86%) as light red powder. Analytical results are shown in Figs S11 (ESI-HR-MS) and S12 (IR spectral analysis).
Synthesis of compound C-3
To a solution of compound 7 (30 mg, 55 lmol, 1.0 equiv.) in 3 mL DMF was added anhydrous potassium carbonate (15 mg, 110 lmol, 2.0 equiv.), the solution was stirred at room temperature for 10 min. Subsequently, compound 3 (20 mg, 66 lmol, 1.2 equiv.) was added and the mixture was stirred for another 10 h. After the reactant was consumed, the reaction mixture was diluted with 20 mL ethyl acetate and extracted with water. The organic layer was washed with water, saturated NaHCO 3 solution and saturated NaCl solution, dried with anhydrous sodium sulfate, filtered, and concentrated in vacuum. The residue was purified by silica gel column chromatography (cyclohexane/ ethyl acetate = 5 : 1) to give compound C-3 (32 mg, 42 lmol, 77%) as red powder. Analytical results are shown in Figs S13 (ESI-HR-MS) and S14 (IR spectral analysis).
Synthesis of compounds C-4 to C-7
To a solution of cinobufagin (30 mg, 68 lmol, 1.0 equiv.) and DMAP (2 mg, 14 lmol, 0.2 equiv.) in 3 mL anhydrous dichloromethane was added the corresponding compound 6a-d (1.2 equiv.), the solution was cooled to 0°C using ice bath and then 20 lL DIC (17 mg, 136 lmol, 2.0 equiv.) was added dropwise. After the addition was completed, the reaction mixture was allowed to reach room temperature and stirred under argon for 24 h. Then the solution was diluted with 15 mL dichloromethane and extracted with water. The organic layer was washed with saturated NaHCO 3 solution and saturated NaCl solution in sequence, dried with anhydrous sodium sulfate, filtered, and evaporated to dryness. The resulting residue was subjected to flash silica gel column chromatography (petroleum/ethyl acetate = 2 : 1) give the compounds C-4 to C-7 as red powders. Owing to the paramagnetic nature of the spin labels, it is difficult to gain valuable structural information by NMR spectroscopy. In order to prove the presence of nitroxide groups, we collected EPR spectra of the target compounds. These gave a three-line spectrum with hyperfine coupling constants in the range of 16.00-16.45 Gauss due to the interaction between the unpaired electron and the nitrogen nucleus. The structures of all the target compounds were further identified by ESI-HR-MS (Figs S15, S17, S19 and S21) and IR spectral analysis (Figs S16, S18, S20 and S22). Optical rotations were also determined. The physical and spectroscopy characters of compounds C-1 to C-7 are listed in Tables S1, S2 and S3.
Preparation and activity assay of Na + ,K + -ATPase Na + ,K + -ATPase from pig kidney microsomal membranes was purified by differential centrifugation [11] . The stock solution has protein concentration of 5-6 mgÁmL À1 in 250 mM sucrose, 20 mM histidine, 0.9 mM EDTA (pH 7.0). The specific Na + ,K + -ATPase activity was determined from the difference in the amount of phosphate released in the absence and presence of 1 mM ouabain in a solution containing 130 mM NaCl, 20 mM KCl, 4 mM MgCl 2 , and 3 mM ATP. The specific activity of the enzyme preparation was approximately 30 lmol P i /mg protein released per min at 37°C [11] . The phosphorylation capacity is about 2.9 nmolÁmg À1 protein and is equal to the high-affinity ouabain-binding capacity [4, 11] .
Details of the cinobufagin spin label inhibition experiments
Stock solutions of the inhibitors, typically 10 mM, were prepared in DMSO. The inhibitory effects of cinobufagin spin labels on Na + , K + -ATPase were determined essentially as previously reported [4] . In brief, Na + ,K + -ATPase is preincubated at 37°C for 3 h in the presence of 3 mM MgCl 2 , 3 mM NMG-phosphate and 40 mM Tris (pH 7.0) with increasing concentrations of inhibitor. For each inhibitor concentration, the residual Na + ,K + -ATPase activity is subsequently determined by 40-fold dilution into a standard ATPase assay medium. Measurements were performed in triplicate and expressed in percent of the Na + ,K + -ATPase activity in the absence of inhibitor (see legend to Fig. 2 for details) .
Details of the kinetic analysis of inhibition
The interaction between cinobufagins (I) and Na
ATPase (E) is interpreted as a two-step process:
where both complexes E•I and E•I* are enzymatically inactive and in relatively slow equilibrium (details of this model can be found in refs. [3, 4] ). The binding of I to E is described by a dissociation constant
The conformational change E•I ↔ E•I* is described by an is described constant
The data are fitted by a nonlinear least squares function relating the Na + ,K + -ATPase activity (Activity(I)) at a given concentration of inhibitor [I] to a sum of two hyperbolic terms containing the parameters for the high-affinity as well as the low-affinity components of inhibition:
The two components have magnitudes of F high and F low (in %). The dissociation constant derived from the curve fitting (K Diss,high ) is related to K i and
Following the above analysis, the relative magnitude of the high-and low-affinity component is a measure of K C .
The seven inhibitors have widely different kinetic properties, and it is illustrative to consider one of them in detail. Compound C-4 inactivates the Na + ,K + -ATPase with about 75% (= F high ) of the activity being very sensitive toward the inhibitor and the remaining activity is not affected by further increase in inhibitor concentration (there is virtually no lowaffinity inactivation in the concentration ranges studied here, K Diss,low is, thus, too large to be determined in the present assay, Fig. 2 and Table 1 ). The simplest interpretation of the above finding is that the equilibrium between E•I and E•I* is displaced 3.00-fold (= K c ) toward E•I*, which represents 75% of the enzyme. K i = K Diss,high (K c + 1) = 0.952 lM, indicating a much stronger initial binding of this compound than for compounds C-2 to C-7 ( Table 1) .
Binding of cinobufagin spin labels to Na + ,K + -ATPase In some experiments, higher enzyme and spin label concentrations were used as indicated in the figures. Cinobufagin spin label binding is carried out at 37°C for 3 h and the reaction is started by the addition of a spin label. Ouabain-containing samples were preincubated with 0.5 mM ouabain at 37°C for 30 min before the addition of a spin label.
After incubation, the samples were cooled and centrifuged 26 500 g at 10°C for 30 min. Pellets were transferred to quartz capillaries with inner diameter 1 mm and stored at À20°C. The samples used for EPR were all subjected to centrifugation in order to increase the concentration of enzyme in the EPR tubes (Figs 4-6 ). The effect of centrifugation is shown in Fig. 10 . The overall shapes of the spectra are very similar, suggesting that centrifugation does not alter the EPR characteristics. In the spectra of the sample before centrifugation (red lines) a small sharp component is visible especially in the high-field section (marked with D in Fig. 10A,B) . After centrifugation this peak is almost absent (black lines). This suggests that spin label in the aqueous phase gives rise to this sharp peak. The enzyme concentration in the pellet is 5-10 times larger than before centrifugation, and the relative contribution from free spin label in the pellet will thus be negligible (in these normalized spectra) compared to the situation before centrifugation.
In Fig. 4A a comparison is made between the spectrum in the absence of ouabain and a spectrum representing the spin label not bound to the specific sites. The amount of spin label bound to the specific site is calculated using the equation
where E tot and I tot are the total concentrations of the enzyme and the spin label, respectively. For E tot = 12 lM, I tot = 4 lM, and K Diss = 0.15 lM (Table 1) , we find EI/ I tot = 0.982 (=98.2%) and the concentration of spin label not bound to the specific sites thus amounts to 1.8% (indicated by the cyan line in Fig. 4A ). The contribution of nonspecifically bound spin label to the full spectrum is similarly indicated with cyan lines in Fig. 4B ,C, and by dotted lines in Fig. 6B .
EPR spectroscopy
The EPR measurements were carried out on a 9-GHz Bruker EMX plus EPR spectrometer (Bruker Biospin, Rheinstetten, Germany). All spectra were recorded at 25°C and the temperature was set by the internal temperature controller of the spectrometer. The samples were placed into thin glass capillaries (~1 mm inner diameter, BLAU-BRAND micropipettes), these were placed in Wilmad Lab Glass standard 4 mm OD quartz EPR tube (Rotec Spintec GmbH, Griesheim, Germany) which were then mounted in the spectrometer. EPR spectra were recorded at X-band frequency (9.4 GHz) with a microwave power of 20 mW and a modulation frequency 100 kHz. The sweep width was 100 G, modulation amplitude 1.25 G, time constant 10 ms. The typical sweep time was 60 s, and 16 scans were summed in order to improve the signal-to-noise ratio. Spectra were characterized using the approaches in ref. [12] .
Docking procedures
The crystal structure of Na + ,K + -ATPase in complex with bufalin (PDB ID 4RES) was used for docking of spinlabeled cinobufagins [3] . The docking model was prepared using the Protein Preparation Wizard in the Schr€ odinger Suite 2012. The protonation states of the titratable groups in the structure were deduced from pKa values calculated in PROPKA.
Bufalin and spin-labeled cinobufagins were built in Maestro version 11.2 and the protonation state of each compound was predicted in Epik. A conformational search was performed by the Advanced Search procedure using the OPLS3 force field. Each step in the conformational search was followed by a 2500-step minimization or until the minimization reached convergence using a conjugate gradient algorithm. The obtained lowest-energy conformation of each compound was used for docking.
A receptor grid centered on the bufalin-binding site was generated and docking was performed in Glide. The docking included flexible ligand sampling and was set up to retrieve a maximum of 100 poses. The final scoring was achieved using the XP protocol, all other settings were default. Docking of bufalin and cinobufagin placed both ligands in the position of bufalin in the crystal structure, thus verifying the docking approach. Docking of bufalin, cinobufagin, and spin-labeled cinobufagins resulted in scores around À7. 
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